Hall 8a, booth F39.1
Our highlight exhibit is the CTCelect system, a platform technology for liquid biopsy sample processing and analysis. Its main function is the isolation and single cell enrichment for next generation sequencing analyses of the individual CTCs. We also present the Simplex system, a mobile, autonomously working platform for the point-of-care diagnosis of influenza. With Simplex it is possible to determine besides the infection status of the patient even the subtype of the influenza virus. The portfolio is completed by further microfluidic components.Fraunhofer IMM is a leading contract research organization that has been providing innovative research and development services for over 30 years. With a clear focus on the energy, chemical and diagnostic sectors, the institute works on practical solutions for industry, research institutions and universities.
The project work of IMM supports strategic research fields such as hydrogen technologies, resource efficiency, climate protection, digital health and bioeconomy. In doing so, the institute is guided by global challenges and the goals of sustainable development.
The topics of clean energy, sustainability and health are at the center of its work.The expertise of the Fraunhofer IMM is based on its core competencies in the areas of materials, technologies, processes and engineering. These enable the efficient implementation of complex projects:
The Fraunhofer IMM consistently pursues the goal of developing sustainable and marketable solutions that not only strengthen the competitiveness of its partners, but also actively contribute to solving societal challenges.